2 Reasons Why Alnylam Pharmaceuticals Stock Gained 18.5% In November

According to data from S&P Global Market Intelligence, shares of the leading RNA interference drugmaker Alnylam Pharmaceuticals (NASDAQ: ALNY) gained 18.5% last month. The biotech's stock was lifted up by both the insurgent victory of Donald Trump -- presumably because of his less vitriolic stance on U.S. drug pricing schemes than Hillary Clinton -- along with Sanofi's (NYSE: SNY) decision to opt-in to co-develop and co-commercialize the experimental hemophilia treatment fitusiran in the United States, Canada, and Western Europe.Prior to last month's rally, Alnylam's stock was in a tailspin as a result of its decision to discontinue the development of the late-stage hereditary ATTR amyloidosis drug candidate revusiran.

BING NEWS:
  • Stock market crash today: Why is Indian stock market falling for last three days? Explained with 5 reasons
    Premium Stock market crash: Rising US dollar and Treasury yields, disappointing US retail sales data, falling Indian National Rupee (INR), and rising crude oil prices are some other reasons that ...
    04/15/2024 - 4:13 am | View Link
  • Alnylam Pharmaceuticals, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations
    NEW YORK, NY / ACCESSWIRE / April 11, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Alnylam ...
    04/11/2024 - 2:20 am | View Link
  • Why is Indian stock market flirting with record highs? — explained with 5 reasons
    Premium Stock market today: The Nifty 50 index hit a new high of 22,768 level, the BSE Sensex touched a new lifetime high of 75,124 mark while the Bank Nifty today climbed to a new record high of ...
    04/9/2024 - 6:26 am | View Link
  • Are Medical Stocks Lagging ASLAN Pharmaceuticals (ASLN) This Year?
    Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is ASLAN Pharmaceuticals Ltd. (ASLN) one of those stocks right now? Let's take a ...
    04/9/2024 - 2:40 am | View Link
  • Analysts Have Conflicting Sentiments on These Healthcare Companies: Alnylam Pharma (ALNY), Gilead Sciences (GILD) and Agios Pharma (AGIO)
    Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Alnylam Pharma (ALNY – Research Report), ...
    04/8/2024 - 3:50 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News